Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Following infection, antibodies are formed against the spike (S) and nucleocapsid (N) proteins, which are the primary viral antigens of SARS-CoV-2. This study aims to determine the antibody response thr...

Full description

Bibliographic Details
Main Authors: S. Thasneem Banu, S. Vinotha, Radhika Katragadda, R. Vanaja
Format: Article
Language:English
Published: Journal of Pure and Applied Microbiology 2023-03-01
Series:Journal of Pure and Applied Microbiology
Subjects:
Online Access:https://microbiologyjournal.org/seroconversion-in-covid-19-infection-and-comparison-of-antibody-responses-in-symptomatic-versus-asymptomatic-individuals/
_version_ 1797867147607670784
author S. Thasneem Banu
S. Vinotha
Radhika Katragadda
R. Vanaja
author_facet S. Thasneem Banu
S. Vinotha
Radhika Katragadda
R. Vanaja
author_sort S. Thasneem Banu
collection DOAJ
description Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Following infection, antibodies are formed against the spike (S) and nucleocapsid (N) proteins, which are the primary viral antigens of SARS-CoV-2. This study aims to determine the antibody response three weeks post-infection and its persistence. To study antibody responses in COVID-19-positive individuals and to compare the degree of antibody response in symptomatic and asymptomatic individuals. The persistence of the antibody response was also assessed. Adult patients (> 15 years of age) who were diagnosed as COVID-19-positive by RT-PCR, three weeks after swab positivity were tested for total antibody levels against COVID-19 antigens by electrochemiluminescence assay. Out of 226 individuals, 129 were symptomatic and 97 were asymptomatic. Among the 129 symptomatic individuals, 74 exhibited an antibody response, whereas in the asymptomatic individuals, only 10 exhibited an antibody response. The antibody response was found to be significant in symptomatic individuals compared to that in asymptomatic individuals (p < 0.05). All follow-up individuals were seropositive at the end of both 6 and 8 months. Antibodies against SARS-CoV-2 persist for 8 months following infection. Despite the waning of antibodies against the nucleocapsid antigen, there was no complete disappearance of antibodies.
first_indexed 2024-04-09T23:35:41Z
format Article
id doaj.art-f006a307e76d41918e0a554ef6689039
institution Directory Open Access Journal
issn 0973-7510
2581-690X
language English
last_indexed 2024-04-09T23:35:41Z
publishDate 2023-03-01
publisher Journal of Pure and Applied Microbiology
record_format Article
series Journal of Pure and Applied Microbiology
spelling doaj.art-f006a307e76d41918e0a554ef66890392023-03-20T12:14:22ZengJournal of Pure and Applied MicrobiologyJournal of Pure and Applied Microbiology0973-75102581-690X2023-03-01171590596https://doi.org/10.22207/JPAM.17.1.56Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic IndividualsS. Thasneem Banuhttps://orcid.org/0000-0001-7810-8183 S. Vinothahttps://orcid.org/0000-0003-1625-8869Radhika Katragaddahttps://orcid.org/0000-0002-6756-7306R. Vanajahttps://orcid.org/0009-0001-2465-3917Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Following infection, antibodies are formed against the spike (S) and nucleocapsid (N) proteins, which are the primary viral antigens of SARS-CoV-2. This study aims to determine the antibody response three weeks post-infection and its persistence. To study antibody responses in COVID-19-positive individuals and to compare the degree of antibody response in symptomatic and asymptomatic individuals. The persistence of the antibody response was also assessed. Adult patients (> 15 years of age) who were diagnosed as COVID-19-positive by RT-PCR, three weeks after swab positivity were tested for total antibody levels against COVID-19 antigens by electrochemiluminescence assay. Out of 226 individuals, 129 were symptomatic and 97 were asymptomatic. Among the 129 symptomatic individuals, 74 exhibited an antibody response, whereas in the asymptomatic individuals, only 10 exhibited an antibody response. The antibody response was found to be significant in symptomatic individuals compared to that in asymptomatic individuals (p < 0.05). All follow-up individuals were seropositive at the end of both 6 and 8 months. Antibodies against SARS-CoV-2 persist for 8 months following infection. Despite the waning of antibodies against the nucleocapsid antigen, there was no complete disappearance of antibodies.https://microbiologyjournal.org/seroconversion-in-covid-19-infection-and-comparison-of-antibody-responses-in-symptomatic-versus-asymptomatic-individuals/covid-19rt-pcrelectrochemiluminescence assay
spellingShingle S. Thasneem Banu
S. Vinotha
Radhika Katragadda
R. Vanaja
Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
Journal of Pure and Applied Microbiology
covid-19
rt-pcr
electrochemiluminescence assay
title Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
title_full Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
title_fullStr Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
title_full_unstemmed Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
title_short Seroconversion in COVID-19 Infection and Comparison of Antibody Responses in Symptomatic Versus Asymptomatic Individuals
title_sort seroconversion in covid 19 infection and comparison of antibody responses in symptomatic versus asymptomatic individuals
topic covid-19
rt-pcr
electrochemiluminescence assay
url https://microbiologyjournal.org/seroconversion-in-covid-19-infection-and-comparison-of-antibody-responses-in-symptomatic-versus-asymptomatic-individuals/
work_keys_str_mv AT sthasneembanu seroconversionincovid19infectionandcomparisonofantibodyresponsesinsymptomaticversusasymptomaticindividuals
AT svinotha seroconversionincovid19infectionandcomparisonofantibodyresponsesinsymptomaticversusasymptomaticindividuals
AT radhikakatragadda seroconversionincovid19infectionandcomparisonofantibodyresponsesinsymptomaticversusasymptomaticindividuals
AT rvanaja seroconversionincovid19infectionandcomparisonofantibodyresponsesinsymptomaticversusasymptomaticindividuals